Diazepam Injection
Product Images NDC 0404-9769

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diazepam (NDC 0404-9769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
This text provides dosage guidelines for a medication used in the treatment of anxiety disorders, symptoms of anxiety, acute alcohol withdrawal, endoscopic procedures, and muscle spasms associated with certain conditions. Dosages range from 2mg to 10mg and can be administered intramuscularly or intravenously. The text also highlights specific dosages for different age groups and conditions, with the recommendation to administer slowly and to adjust dosage based on the desired sedative response. For tetanus in infants over 30 days old, a dosage of 1mg to 2mg is advised, while in children 5 years or older, 5mg to 10mg may be necessary. Respiratory assistance should be readily available, especially for cases involving muscle spasm.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
This text presents guidelines for the management of Status Epilepticus, emphasizing the preferred use of intravenous administration for medication such as diazepam. The initial dosage for adults and children in this situation is provided, along with recommendations for subsequent doses if required. Caution is advised, particularly with patients having chronic lung disease or unstable cardiovascular status. Additionally, the text includes information on preoperative medication administration and cardioversion, recommending specific dosages for these situations. EEG monitoring of seizures and the administration routes are also discussed in the context of Status Epilepticus and preoperative care.*
FDA Label Image

Image4.jpg (Image4)

Image4.jpg (Image4)
This is a description for Figure 1 showing an external collar labeled as "Esternal Collar" with a warning not to remove it. Below the collar is a part labeled as "Plunger Rod".*
FDA Label Image

Image5.jpg (Image5)

FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
This is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.